Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Chronic PainPelvic Pain

Interventions

DRUG

Intranasal Oxytocin

Intranasal oxytocin (Syntocinon; Novartis, Switzerland)

DRUG

Placebo

Placebo nasal spray

Trial Locations (1)

Behavioural Medicine Laboratory, Calgary

All Listed Sponsors

lead

University of Calgary

OTHER

NCT02888574 - Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain | Biotech Hunter | Biotech Hunter